Drug utilisation study of Eliglustat for the treatment of Gaucher Disease Type 1 in Europe using electronic healthcare records (ELIGLC06913) First published 14/04/2020 Last updated 07/05/2025 EU PAS number:EUPAS34611 Study Finalised